An arsenic-chelating metallothionein (fMT) from the arsenic-tolerant marine alga Fucus vesiculosus was expressed in Escherichia coli, resulting in 30-and 26-fold-higher As(III) and As(V) binding, respectively. Coexpression of the As(III)-specific transporter GlpF with fMT further improved arsenic accumulation and offered high selectivity toward As. Resting E. coli cells coexpressing fMT and GlpF completely removed trace amounts (35 ppb) of As(III) within 20 min, providing a promising technology for compliance with the As limit of 10 ppb newly recommended by the U.S. EPA.Arsenic (As), a metalloid, is a known human carcinogen affecting millions of people worldwide (25,33). Arsenic exists in two forms: trivalent arsenite [As(III)] and pentavalent arsenate [As(V)]. Exposure to As can result in increased risks of hypertension (5, 6), skin, lung, and bladder cancers (14), and hyperkeratosis (4), due to inhibition of oxidative phosphorylation (11), interference with cell signaling by binding to hormone receptors (12), or generation of reactive oxygen species (19).Conventional techniques for As treatment are mostly ineffective for the uncharged form, As(III) (9, 37), or at low arsenic concentrations. Recently, bioremediation has been gaining momentum as an environmentally friendly and effective alternative for removal of heavy metals (6,7,15,18,22,26). Although metal-chelating peptides such as metallothionein (MT) have been overexpressed in microorganisms for enhanced accumulation of Cd and Cu, almost all such peptides lack specificity for As (1,2,20,29,31,34,35). Specific arsenic accumulation has been reported by utilizing the metalloregulatory protein ArsR (16) or phytochelatins (13,21,32). However, enzymatic synthesis and the availability of precursors such as glutathione and ␥-glutamylcysteine require actively growing cells and limit the utility of the metal-chelating ArsR and phytochelatins.Recently, a newly identified MT from an arsenic-tolerant marine alga, Fucus vesiculosus (fMT), has been cloned and stably expressed as a fusion protein (24) in Escherichia coli and has been shown to bind arsenite with high affinity in vitro (23). However, the utility of E. coli cells expressing fMT for As removal has not been reported. Here we report the overexpression of fMT in E. coli for enhanced accumulation of both As(V) and the uncharged form, As(III). To remove the bottleneck in As(III) uptake, the As(III) transporter GlpF was coexpressed with fMT, resulting not only in further improvement in As(III) accumulation but also in selectivity for As(III). Even resting cells could remove trace amounts of As(III) within 20 min.Expression of recombinant fMT and its effect on arsenic accumulation.